当前位置:首页 - 行情中心 - 亚太药业(002370) - 财务分析 - 现金流量表

亚太药业

(002370)

  

流通市值:45.34亿  总市值:45.34亿
流通股本:7.46亿   总股本:7.46亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金89,348,452.0839,441,013.53253,785,396.08193,325,869.73
  收到其他与经营活动有关的现金35,185,164.715,740,593.812,249,568.3813,652,870.48
  经营活动现金流入小计124,533,616.7855,181,607.33266,034,964.46206,978,740.21
  购买商品、接受劳务支付的现金26,748,846.049,510,992.1472,607,975.5248,607,372.87
  支付给职工以及为职工支付的现金36,570,938.1621,021,711.569,459,330.2854,735,054.48
  支付的各项税费7,459,829.035,865,391.8822,792,945.9220,425,010.01
  支付其他与经营活动有关的现金25,857,352.367,208,712.6876,821,604.4247,341,026.99
  经营活动现金流出小计96,636,965.5943,606,808.2241,681,856.14171,108,464.35
  经营活动产生的现金流量净额27,896,651.1911,574,799.1324,353,108.3235,870,275.86
二、投资活动产生的现金流量:
  收回投资收到的现金329,615.14329,615.14903,131.261
  取得投资收益收到的现金910,465.4-16,023,045.731,992,687.67
  处置固定资产、无形资产和其他长期资产收回的现金净额7,900--122,858.49-
  处置子公司及其他营业单位收到的现金净额126,268,279.9330,000,000--
  收到的其他与投资活动有关的现金50,675,408.161,924,030.27-33,375
  投资活动现金流入小计178,191,668.6332,253,645.4116,803,318.52,026,063.67
  购建固定资产、无形资产和其他长期资产支付的现金2,244,962417,4549,794,862.27,133,372.29
  投资活动现金流出小计2,244,962417,4549,794,862.27,133,372.29
  投资活动产生的现金流量净额175,946,706.6331,836,191.417,008,456.3-5,107,308.62
三、筹资活动产生的现金流量:
  取得借款收到的现金--30,000,000-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计0-30,000,000-
  偿还债务支付的现金277,225,300-50,000,00050,000,000
  分配股利、利润或偿付利息支付的现金37,371,378.34246,500.0111,901,761.811,901,761.8
  支付其他与筹资活动有关的现金--3,604.42-
  筹资活动现金流出小计314,596,678.34246,500.0161,905,366.2261,901,761.8
  筹资活动产生的现金流量净额-314,596,678.34-246,500.01-31,905,366.22-61,901,761.8
五、现金及现金等价物净增加额-110,753,320.5243,164,490.53-543,801.6-31,138,794.56
  加:期初现金及现金等价物余额719,698,723.26719,698,723.26720,242,524.86720,242,524.86
  期末现金及现金等价物余额608,945,402.74762,863,213.79719,698,723.26689,103,730.3
补充资料:
  净利润105,176,469.82-34,239,781.33-
  资产减值准备5,029,349-5,563,928.48-
  固定资产和投资性房地产折旧14,227,000.21-31,172,474.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,227,000.21-31,172,474.31-
  无形资产摊销2,896,448.04-5,753,973.97-
  长期待摊费用摊销100,440-208,758.69-
  处置固定资产、无形资产和其他长期资产的损失--7,367.1-
  固定资产报废损失19,076.46-127,358.49-
  公允价值变动损失-952,429.21--1,638,089.72-
  财务费用34,642,973.19-30,590,222.13-
  投资损失-150,281,649.56--53,816,793.8-
  递延所得税142,864.37-245,713.46-
    递延所得税负债增加142,864.37-245,713.46-
  存货的减少1,330,008.62-13,816,027.95-
  经营性应收项目的减少-630,494.73-3,541,510.73-
  经营性应付项目的增加17,061,757.18--45,491,317.36-
  债务转为资本--358,259,900-
  现金的期末余额608,945,402.74-719,698,723.26-
  减:现金的期初余额719,698,723.26-720,242,524.86-
  现金及现金等价物的净增加额-110,753,320.52--543,801.6-
公告日期2025-08-302025-04-302025-04-252024-10-31
审计意见(境内)标准无保留意见
TOP↑